Literature DB >> 9099979

Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.

P Würl1, H Taubert, A Meye, T Dansranjavin, E Weber, D Günther, D Berger, H Schmidt, H Dralle, F W Rath.   

Abstract

Lysosomal proteases are known to enhance the spread of epithelial tumour cells, but little is known of the possible role of proteases in the growth of soft tissue sarcomas (STS). We investigated the expression of cathepsins D, B, S, H, L and procathepsin L in frozen sections of 34 STS from 34 patients by immunohistochemistry (IHC). Cathepsins D, B and H were relatively highly expressed in STS (77-91%). The expression rate of cathepsins S and L and of procathepsin L was lower (40-66%). Cathepsin S and L expression showed a moderate (P = 0.078 and P = 0.019) and procathepsin L a strong (P = 0.00001) correlation with the survival rate of STS patients. Cathepsin S expression is also correlated with the local recurrence rate (P < 0.01). Lysosomal proteases may play a role in STS progression, and cathepsin expression may also have significance as a prognostic factor in STS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099979     DOI: 10.1007/bf01324805

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  39 in total

1.  Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.

Authors:  A F Chambers; R Colella; D T Denhardt; S M Wilson
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

2.  Antibodies to rat liver cathepsins: characterization and use for the identification of enzyme precursors.

Authors:  B Wiederanders; H Kirschke
Journal:  Biomed Biochim Acta       Date:  1986

3.  Cathepsin S and related lysosomal endopeptidases.

Authors:  H Kirschke; B Wiederanders
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues.

Authors:  M R Buck; D G Karustis; N A Day; K V Honn; B F Sloane
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

5.  Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.

Authors:  S Veneroni; M G Daidone; G Di Fronzo; V Cappelletti; D Amadori; A Riccobon; A Paradiso; M Correale; R Silvestrini
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

6.  Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer.

Authors:  W Remmele; J Sauer-Manthey
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins.

Authors:  H Kirschke; B Wiederanders; D Brömme; A Rinne
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

8.  Cervical lymph node status and survival in laryngeal carcinoma: prognostic factors.

Authors:  J M Resnick; D Uhlman; G A Niehans; M Gapany; G Adams; D Knapp; W Jaszcz
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-09       Impact factor: 1.547

9.  Immunocytochemical and immunoelectron microscopic demonstration of cathepsin B in human malignant melanoma.

Authors:  E Fröhlich; G Schaumburg-Lever; C Klessen
Journal:  Br J Dermatol       Date:  1995-06       Impact factor: 9.302

10.  An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.

Authors:  A J Dickinson; S B Fox; P V Newcomb; R A Persad; G N Sibley; A L Harris
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

View more
  3 in total

1.  Tumoral environment triggers transcript anomalies in established tumors: induction of altered gene expression and of aberrant, truncated and B2 repeat-containing gene transcripts.

Authors:  P Rottiers; M Desmedt; H Dooms; R Contreras; J Grooten
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

2.  The clinical significance of cathepsin S expression in human astrocytomas.

Authors:  Thomas Flannery; David Gibson; Menakshi Mirakhur; Stephen McQuaid; Caroline Greenan; Anne Trimble; Brian Walker; Derek McCormick; Patrick G Johnston
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

3.  Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging.

Authors:  Jeffrey K Mito; Jorge M Ferrer; Brian E Brigman; Chang-Lung Lee; Rebecca D Dodd; William C Eward; Lisa F Marshall; Kyle C Cuneo; Jessica E Carter; Shalini Ramasunder; Yongbaek Kim; W David Lee; Linda G Griffith; Moungi G Bawendi; David G Kirsch
Journal:  Cancer       Date:  2012-03-21       Impact factor: 6.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.